MITHRACIN vs RECLAST

Independent side-by-side comparison.

Rated against independent regulatory sources·Last updated August 20, 2026·How we rate

Possible drug interaction. MITHRACIN and RECLAST are different prescription medicines. Combining or switching between them can cause interactions — talk to a pharmacist or prescriber before making changes. This page is not medical advice.

Attribute	MITHRACIN	RECLAST
Rating	64/100	68/100
Pharmacy pays	—	$0.47 /mL
Type	RX	RX
Active ingredient	PLICAMYCIN	ZOLEDRONIC ACID
Manufacturer	Pfizer	Sandoz
Dosage forms	Injectable	Injectable
Drug class	—	Bisphosphonate
Boxed warning	None	None
Treats	Hypercalcemia, Extramammary Paget Disease, Testicular Neoplasms	Bone Neoplasms, Hypercalcemia, Multiple Myeloma

mithracin reclast

Rating

64/100

68/100

Pharmacy pays

—

$0.47 /mL

Type

Active ingredient

PLICAMYCIN

ZOLEDRONIC ACID

Manufacturer

Pfizer

Sandoz

Dosage forms

Injectable

Drug class

—

Bisphosphonate

Boxed warning

None

Treats

Hypercalcemia, Extramammary Paget Disease, Testicular Neoplasms

Bone Neoplasms, Hypercalcemia, Multiple Myeloma

Frequently asked questions

Which is better-rated, Mithracin or Reclast?

By our independent rating, Reclast scores higher — 3.4 vs 3.2 out of 5 for Mithracin. Ratings are based on FDA regulatory (recall-safety) data.

What is the difference between Mithracin and Reclast?

Mithracin contains Plicamycin, while Reclast contains Zoledronic Acid — they have different active ingredients.

Ratings are based on FDA regulatory (recall-safety) data. This comparison is for general reference only — not medical advice. Always consult a licensed professional before choosing or switching a medication.